dc.contributor.author | Rugge, J. Bruin | eng |
dc.contributor.author | Lochner, Jennifer E. | eng |
dc.contributor.author | Judkins, Dolores Zegar | eng |
dc.date.issued | 2006 | eng |
dc.description.abstract | Screening patients with chronic hepatitis B infection (HBsAg+) for hepatocellular carcinoma by alpha-fetoprotein (AFP) or by AFP plus ultrasound (AFP/US) detects hepatocellular carcinoma tumors at earlier stages and increases resection rates (strength of recommendation [SOR]: B, based on a systematic review of fair-quality randomized controlled trials). It is unclear whether screening with AFP or AFP/US improves disease-specific or all-cause mortality (SOR: B). | eng |
dc.identifier.uri | http://hdl.handle.net/10355/3573 | eng |
dc.language | English | eng |
dc.publisher | Family Physicians Inquiries Network | eng |
dc.relation.ispartofcollection | Clinical Inquiries, 2006 (MU) | eng |
dc.relation.ispartofcommunity | University of Missouri--Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network | eng |
dc.relation.ispartofseries | Journal of family practice, 55, no. 02 (February 2006) | eng |
dc.rights | OpenAccess. | eng |
dc.rights.license | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License. | eng |
dc.subject | ultrasound | eng |
dc.subject | resection rates | eng |
dc.subject | alpha-fetoprotein (AFP) | eng |
dc.subject | serum markers | eng |
dc.subject.lcsh | Liver -- Cancer | eng |
dc.subject.lcsh | hepatitis B | eng |
dc.subject.lcsh | alpha-fetoprotein | eng |
dc.subject.mesh | Carcinoma, Hepatocellular | eng |
dc.title | What is the best surveillance for hepatocellular carcinoma in chronic carriers of hepatitis B? | eng |
dc.type | Article | eng |